Press Releases



 
Press Releases
  Date Title View
Sep 28, 2005
REDWOOD CITY, Calif., Sept. 28, 2005 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced the pricing of its initial public offering of 5,016,722 shares of its Common Stock at $12.00 per share. J.P. Morgan Securities Inc. and Lehman Brothers Inc. acted as joint book-running managers for this offering, and Piper Jaffray & Co., Thomas Weise...
PDF
May 17, 2005
ORLANDO - May 17, 2005 - Genomic Health, Inc. announced that results from three independent studies evaluating the Oncotype DX breast cancer assay were presented at the 41st annual meeting of the American Society of Clinical Oncology (ASCO). These studies examined the assay's ability to quantify likelihood of recurrence, predict response to c...
PDF
May 13, 2005
REDWOOD CITY, CA - May 13, 2005 - Genomic Health, Inc. today announced that The American Journal of Managed Care published the results of a comprehensive economic analysis demonstrating that the breast cancer assay, Oncotype DX, which measures gene expression for a 21-gene panel from individual tumor specimens, may improve survival for some pa...
PDF
Dec 10, 2004
A new test can predict both the risk of breast cancer recurrence and may identify women who will benefit most from chemotherapy, according to research supported by the National Cancer Institute (NCI), part of the National Institutes of Health, and performed in collaboration with the National Surgical Adjuvant Breast and Bowel Project (NSABP) a...
PDF
Dec 10, 2004
NSABP and Genomic Health Announce Positive Study Results Demonstrating Oncotype DX Genomic Breast Cancer Assay Predicts Chemotherapy Response ...
PDF
Dec 9, 2004
SAN ANTONIO - Kaiser Permanente researchers are presenting results of a large epidemiologic study of a unique breast cancer test at the 27th Annual San Antonio Breast Cancer Symposium. The KP study shows the test can identify patients with early stage disease who are at low risk of breast cancer death at 10 years. Researchers at Kais...
PDF
Jun 5, 2004
NEW ORLEANS - June 5, 2004 - Genomic Health, Inc. and Istituto Nazionale Tumori, a leading cancer research institute located in Milan, Italy, today announced preliminary results of a clinical trial in which the patterns of expression of a substantial number of genes were clinically correlated to a pathologic complete response to chemotherapy. The s...
PDF
Dec 4, 2003
The NSABP and Genomic Health Announce Positive Results from Large-Scale, Prospective Validation Study to Quantify Breast Cancer Recurrence in Newly Diagnosed Patients ...
PDF
Jun 2, 2003
Collaborator Press Release: Early Studies With Molecular Test Show That Specific Gene Patterns Are Linked To Response To Treatment With Potent EGFR Drug In Patients With Advanced Lung Cancer ...
PDF
Jun 2, 2003
CHICAGO June 2, 2003 — Genomic Health, Inc. today announced encouraging preliminary data in clinical trials using a novel approach to molecular pathology. RNA analysis of thin sections of standard tumor biopsies were used to evaluate panels of genes that may predict breast cancer recurrence and response to chemotherapy as well as response...
PDF
FirstPrevious
...
40
NextLast